11.4
NeuroSense Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
7.38
FY23:
2.92
FY24:
4.40
FY25:
0.78
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
0.34
FY23:
0.27
FY24:
0.17
FY25:
0.25
Total assets
Change from FY21 to FY25
millions USD
FY21:
11.4
FY22:
7.72
FY23:
3.19
FY24:
4.58
FY25:
1.03
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.60
FY22:
1.73
FY23:
3.46
FY24:
1.99
FY25:
2.52
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.83
FY22:
0.15
FY23:
1.49
FY24:
0
FY25:
0.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.01
FY22:
5.84
FY23:
−1.76
FY24:
2.58
FY25:
−1.56
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
11.4
FY22:
7.72
FY23:
3.19
FY24:
4.58
FY25:
1.03
All amounts in millions USD